Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Neurobiological Technologies, Inc. (NTI) (NASDAQ: NTII) is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer’s disease, ischemic stroke, neuropathic pain, and brain cancer. The company employs a strategy of in-licensing late-stage CNS agents and pursues regulatory approval and commercialization either independently or with a strategic partner. The company was founded in 1987 and went public in February 1994. NTI corporate headquarters are located in Emeryville, CA. ( www.ntii.com )
Neurobiological Technologies , Inc.
2000 Powell Street Suite 800
Emeryville, California 94608
USA
Tel: (510) 595-6000
Fax: (510) 595-6006